Medtronic Receives FDA Approval for 200mm and 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of... Devices, Interventional, FDA Medtronic, IN.PACT Admiral, Drug-Coated Balloon, peripheral artery disease

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2043991

Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Peripheral Vascular Disease (PVD) | Pharmaceuticals